GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 127 filers reported holding GOSSAMER BIO INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $9 | – | 10,505 | +10405.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 100 | -99.8% | 0.00% | – |
| Q4 2022 | $130 | -99.9% | 60,345 | +190.3% | 0.00% | – |
| Q3 2022 | $249,000 | +47.3% | 20,788 | +2.7% | 0.00% | – |
| Q2 2022 | $169,000 | +576.0% | 20,238 | +595.5% | 0.00% | – |
| Q1 2022 | $25,000 | -86.2% | 2,910 | -81.8% | 0.00% | – |
| Q4 2021 | $181,000 | +277.1% | 16,029 | +204.3% | 0.00% | – |
| Q1 2021 | $48,000 | -70.6% | 5,267 | -68.8% | 0.00% | – |
| Q4 2020 | $163,000 | +10.9% | 16,906 | +42.2% | 0.00% | – |
| Q3 2020 | $147,000 | +167.3% | 11,889 | +179.5% | 0.00% | – |
| Q2 2020 | $55,000 | -87.3% | 4,254 | -90.1% | 0.00% | -100.0% |
| Q1 2020 | $434,000 | +689.1% | 42,855 | +1190.4% | 0.00% | – |
| Q3 2019 | $55,000 | – | 3,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
| Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
| Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
| Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
| HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
| Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
| Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
| EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |